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ABSTRACT
Glucose-6-phosphate  dehydrogenase  (G6PD)  is  an  important  site  of  metabolic  control  in  the 
pentose  phosphate  pathway  (PPP)  which  provides  reducing  power  (NADPH)  and  pentose 
phosphates. The former is mainly involved in the detoxification of chemical reactive species; the 
latter in the regulation of cell proliferation. G6PD deficiency is the most common enzymopathy in 
the human population, characterized by decreased G6PD activity, mainly in red blood cells, but 
actually also in nucleated cells. This decreased activity is not due to enzyme synthesis impairment, 
but rather to reduced enzyme stability, which leads to a shortening of its half-life. Therefore,  a 
major problem is to understand the underlying mechanisms linking G6PD deficiency to oxidative 
stress and cell proliferation. In order to address this issue, in the present study we utilized, as an 
experimental model, fibroblasts isolated from pterygium, an ocular proliferative lesion, from G6PD 
normal and deficient (PFs+ and PFs-, respectively) patients. Our choice was determined by the fact 
that pterygium is believed to be caused by chronic oxidative stress induced by UV exposure, and 
that pterygium fibroblasts resemble a tumorigenic phenotype. As controls we utilized fibroblasts 
isolated  from  conjunctiva  from  G6PD  normal  and  deficient  patients  (NCFs+  and  NCFs-, 
respectively) who had undergone cataract surgery. 
Growth rate analysis revealed that PFs grow faster than NCFs, but while NCFs- grow more slowly 
than NCFs+, PFs- and PFs+ grow at the same rate. This was associated with significantly lower 
G6PD activity in NCFs+ compared to NCFs-, while no significant differences in the G6PD activity 
of PFs+ and PFs- were noted. This result was supported by the finding that in PFs-, G6PD mRNA 
levels  were  significantly  higher  than  in  PFs+.  Another  interesting  finding  of  this  study  was 
increased green autofluorescence in both NCFs- and PFs- compared to corresponding positive cells, 
indicative  of  pronounced  oxidative  stress  in  deficient  cells.  Finally,  abnormal  accumulation  of 
neutral lipids, mainly cholesterol esters was observed both in PFs- and PFs+ compared to NCFs- 
and NCFs+. Though further studies are necessary for better understanding the exact mechanism 
which links G6PD to oxidative stress and cell proliferation, our data allow to speculate on the role 
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of  G6PD on  tumorigenesis,  and  to  consider  G6PD-deficient  subjects  at  major  risk  to  develop 
common and dreaded proliferative disorders, such as atherosclerosis and cancer. 
INTRODUCTION
Glucose-6-phosphate  dehydrogenase  deficiency  (G6PD-)  is  an  X-linked  enzymopathy  affecting 
over  400  million  people  worldwide  (1,2)  and  about  250,000  people  in  Sardinia,  11%  of  the 
population  (3).  Nucleotide  sequence  analysis  among  the  G6PD variants  present  in  this  island, 
showed that a C-T transition in exon 6, causing a Ser-Phe amino acid change at position 188 of the 
protein, is responsible for all forms of very severe G6PD deficiency in Sardinia and, possibly, in the 
Mediterranean area as a whole (4). In males affected by this mutation, red cells show less than 5% 
of normal activity; however, enzyme synthesis is unimpaired - rather, enzyme stability is reduced 
(1).The  recent  discovery  of  the  crystalline  structure  of  G6PD  has  provided  insights  into  the 
mechanistic basis of this reduced stability (5). It has been suggested that the mutation causes a loss 
of  normal  folding  of  the  G6PD  protein;  these  unfolded  forms  are  susceptible  to  proteolytic 
degradation and consequently the enzyme has a shorter half-life. The enzyme deficit, albeit to a 
lesser extent, has been found in tissues other than red blood cells (6,7). However, chronic effects of 
G6PD-  in  nucleated  cells  have,  so  far,  received  little  attention,  and  sometimes  conflicting 
conclusions have been drawn (8-11). G6PD, coded by a gene located on the long arm of the human 
X-chromosome, is the key cytosolic enzyme in the pentose- phosphate pathway (PPP), which has a 
major  role  in  generating  both pentose for  acid nucleic  synthesis,  essential  for  cell  growth,  and 
reduced  nicotinamide  adenine  dinucleotide  phosphate  (NADPH),  indispensable  for  reductive 
metabolism and cellular redox homeostasis maintenance (1). Given G6PD’s role in acid nucleic 
synthesis it has been speculated that G6PD deficiency represent a protective factor against disorders 
such  as  tumors  and  cardiovascular  diseases  (8,9,12).  However,  quiescent  nucleated  cells  from 
subjects with severe decrease in erythrocyte enzyme activity produce lower NADPH levels than 
cells  from  erythrocyte-normal  G6PD  (G6PD+)  (6,7),  which  renders  them  more  vulnerable  to 
reactive oxygen compounds and free radicals. Since oxidative stress play a crucial role in cardiac 
and vascular abnormalities as well as in tumor progression (13,14) a question arises as to whether 
G6PD- may represents a factor favoring growth. 
By “pterygium” is usually meant a benign growth of the conjunctiva (15). It is associated with, and 
thought to be caused by, ultraviolet-light (UV) exposure, which may have detrimental effects, either 
directly (UV phototoxic effect), or indirectly, radical oxygen species (ROS) formation (15-17). In a 
previous study we found that the frequency of G6PD deficiency in patients with pterygium was 
higher than expected: 22% in the pterygium population, compared to 11% in the normal population 
(unpublished data). For this reason, fibroblasts isolated from this ocular proliferative lesion, seemed 
to us to be a good experimental model in an attempt to better understand the biological implications 
of G6PD deficiency on cell proliferation. In the present study we evaluated: i) G6PD activity and 
growth  rate,  ii)  G6PD mRNA levels,  in  pterygium fibroblasts  (PFs)  from G6PD+ and G6PD- 
pterygium patients and in conjunctive fibroblasts (NCFs) from G6PD+ and G6PD- cataract_surgery 
patients. In addition, since alterations of cholesterol metabolism, mainly cholesterol esters,  have 
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been found during the growth of PFs, (18-20), iii) cholesterol metabolism was also determined in 
NCFs+, NCFs, PFs+ and PFs-.quiescent and growth stimulated. 
MATERIAL AND METHODS
Fibroblasts isolation 
For fibroblast isolation, we selected eight male patients (4 erythrocyte G6PD+ and 4 erythrocyte 
G6PD-) with primary pterygium (age range, 45–65 years; mean, 57.3 ± 3.5 [SE] years) and eight 
male patients (4 erythrocyte G6PD+ and 4 erythrocyte G6PD-) with normal conjunctiva (age range, 
60–70 years; mean, 63.7 ± 1.4 years), who underwent cataract surgery at the University Eye Clinic 
of Cagliari. All patients with pterygium had at least a 3-year history of a slow-growing lesion, with 
a corneal extension of at least 4 mm, as measured with a caliper, from the limbus to the corneal 
vertex.  No subject in the control group had any inflammatory signs or symptoms. The research 
adhered to the tenets of the Declaration of Helsinki. Written informed consent was obtained from all 
the  patients  before  blood  and  tissues  were collected.  Blood  samples  from these  subjects  were 
utilized for erythrocyte G6PD determination. This study and all the procedures, including biopsy 
from  the  conjunctiva  during  cataract  surgery,  were  approved by  the  Ethics  Committee  of  the 
University  of  Cagliari. All  tissue  samples  were  obtained  as  previously  described  (18-20).   In 
summary, at the time of surgery, tissue was excised from the inner canthus with microforceps. As a 
rule,  within 1 hour of  excision,  samples  were  placed  in  sterile  boxes  containing a  preservative 
solution (Eurocollins; Roche Biochemicals, Mannheim, Germany) and were transferred to the cell 
culture room. For fibroblast isolation, pterygium and normal conjunctiva tissues were dissected into 
three to four tissue fragments (1 mm2). Tissue fragments were placed in six-well plates for 2 hours. 
After 2 hours of adhesion, a few drops of Dulbecco modified Eagle medium (DMEM; Gibco, Grand 
Island, NY) supplemented with 10% fetal bovine serum (FBS; Sigma Aldrich, Munich, Germany), 
100 U/mL penicillin/streptomycin (Sigma Aldrich), and fungizone (Life Technologies, Bethesda, 
MD) were added to cover each fragment. The next day, the tissue fragments were covered with 
culture medium and were  placed in  a humidified incubator  (37°C, 5% CO2).  The medium was 
changed every 2 days. After 5 to 6 days, fibroblasts began to proliferate from the fragment margin 
(halo of cells) and created a monolayer. The outgrowing cells were morphologically consistent with 
fibroblasts by their characteristic spindle shape. After 4 weeks, fibroblasts were purified by repeat 
trypsinization (trypsin/EDTA, 0.05%/0.02%) and passaging to achieve a homogenous population of 
spindle cells. Purified fibroblasts were washed twice with sterile phosphate-buffered saline (PBS) 
and  centrifuged.  Cells  (1  x  106)  were  then  seeded  into  a  25-cm2  culture  flask  and  grown  to 
confluence. At this time, cells were used for in vitro staining experiments or were transferred to 
cryopreservation medium at a suspension of 1 x 107 cells/ml. After swift freezing, fibroblasts were 
placed in liquid nitrogen for long-term storage. Based on the need of experiments, cryopreserved 
cells  were  removed from liquid nitrogen tank and cultured  under the conditions described.  All 
experiments were conducted using fibroblasts between passages 2 to 4. 
Determination of growth rate
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For growth rate determination cells were placed at a density of 40,000 cell/cm2 in six-well plates 
and then were incubated for 24 hours in DMEM with 0.2% FCS to synchronize cells at a quiescent 
state. Quiescent fibroblasts were then diluted in complete growth medium containing 10% FCS. 
Cells were harvested at the indicated time points. Growth rate was assessed by counting cells with a 
hemocytometer and by incorporating 3H-thymidine (10 Ci/ml) into DNA. In this experiment  μ 3H-
thymidine was added 3 hours before harvesting.  Trypan blue uptake was used to determine cell 
viability. 
G6PD activity assay. 
Venous blood from patients and controls was collected in EDTA. Red blood cells were prepared by 
centrifuging  whole blood at  2,000 g for  10 min at  4°C. Plasma and buffy coat were  carefully 
removed and red  cells  were  hemolyzed with 4 vol.  of  cold distilled water.  G6PD activity  was 
evaluated in hemolysates and values expressed as mµmoles of NADPH formed per minute per 10 9 
red cells. In all G6PD deficient subjects analyzed, the residual activity of the enzyme in red blood 
cells was about 2-5% of the activity found in G6PD normal subjects (data not shown). For G6PD 
activity determination in fibroblasts, 106 cells were homogenated with 9 vol. of 50 mmol/l Tris-HCl 
buffer  pH  7.5  containing  0.15  mmol/l  KCl.  G6PD  activity  was  determined  in  fibroblast 
homogenates and expressed as mµmoles of NADPH formed per minute per 106  fibroblasts. 
Determination of intracellular lipid 
To  visualize  intracellular  lipids,  cultured  fibroblasts  were  washed  with  PBS  and  fixed  in  4% 
paraformaldehyde. Cell were then stained with  Oil red-O (ORO) (Sigma), Nile Red and filipin. 
ORO  staining,  specific  for  neutral  lipids,  was  made  in  60% isopropyl  alcohol,  followed  by 
Mayer’s hematoxylin counterstaining. ORO was observed in transmitted white light. 
Nile Red  (9-diethylamino-5H-benzo[α]phenoxazine-5-one)  (Fluka, Buchs, SG, Switzerland) is a 
fluorescent dye which stains differentially polar lipids (i.e., phospholipids) and neutral lipids (i.e., 
cholesterol ester and triglycerides (21). Polar lipids show a prevalent red emission, while neutral 
lipids  show both  a  red  and yellow emission.  Red emission (referred  to  as  Nile  Red-590)  was 
observed with 540±12.5 excitation and 590 LP emission filters. Yellow emission (referred to as 
Nile Red-535) was observed with 460±25 excitation and 535±20 emission filters. Filipin (Sigma) is 
a fluorescent dye which stains only free cholesterol. Filipin was observed with 360±20 excitation 
and 460±25 emission filters.  Filipin and Nile Red emissions  were  completely separated using the 
indicated filters, so that these fluorochromes could be used in combination (21). 
Cells growing in glass-bottomed dishes were observed with an Olympus IX 71 inverted microscope 
(Olympus,  Tokyo,  Japan),  using  a  20x/0.7  or  60x/1.3  planapochromatic  objective  (Olympus 
UPlanSApo series) which provided a good alignment of different color emissions. 12 bit-images 
were  captured  with  a  cooled  CCD  camera  (Sensicam  PCO,  Kelheim,  Germany).  Nominal 
resolutions  of  images  were  0.3  µm/pixel  and  0.1  µm/pixel  for  the  20x  and  60x  objective, 
respectively. Quantitative image analysis was performed with the ImagePro Plus package (Media 
Cybernetics, Silver Springs, MD).
RT-PCR Analysis
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Expression  levels  of  G6PD mRNAs  were evaluated  in  PFs  and  in  NCFs  by  semiquantitative, 
reverse  transcription polymerase  chain  reaction  (RT-PCR) with  ß-actin  as RNA controls.  RNA 
extractions  were  performed in  approximately  106 cells  using reagent (Trizol;  Invitrogen). Equal 
amounts  of  total  RNA (1  µg)  were  reverse  transcribed into  cDNA using  the  random hexamer 
method. cDNA was subsequently amplified by PCR in the presence of specific primers according to 
the  instructions  provided  by  the  manufacturer  (GeneAmp RNA PCR Kit;  Perkin-Elmer  Cetus, 
Foster City, CA). The overall procedure was standardized by expressing the amount of PCR product 
for G6PD mRNA relative to the amount of product formed for ß-actin. The National Institutes of 
Health Image 1.63 Analysis Software program (Scion Image) was used to assess the intensity of the 
bands in the autoradiograms. 
Autofluorecence analysis 
The  intrinsic  autofluorescence  properties  of  fibroblasts  were  investigated  on  single  living 
fibroblasts grown under conditions described above. Cells were viewed by using an Olympus IX 71 
inverted microscope (Olympus, Tokyo, Japan), equipped with 20x/0.7 or 60x/1.3 planapochromatic 
objective  (Olympus  UPlanSApo series). Green  autofluorescence  was detected  under  a  535  nm 
emission signal. Autofluorescence values were  obtained with the ImagePro Plus package (Media 
Cybernetics, Silver Springs, MD). At least 50 cells were measured for each group.
Statistical analysis 
Data were reported as mean ± standard error (SE). Statistical calculations were performed with the 
software  Origin  (Microcal,  Inc,  Northampton,  MA),  and  Statistica  (StatSoft,  Tulsa,  OK). 
Comparisons between data were made with Student t-test. P<0.05 was considered as statistically 
significant.
RESULTS
In  an  attempt  to  better  understand  the  biological  implications  of  G6PD  deficiency  on  cell 
proliferation, in the present study we analyzed the correlation between growth rate, G6PD activity, 
and lipid metabolism in primary culture of fibroblasts  isolated from human normal conjunctiva 
(NCFs) and pterygium (PFs) of erythrocyte G6PD normal (G6PD+) and deficient (G6PD-) male 
subjects.
Growth rate in NCFs and PFs 
Growth rate analysis, assessed by counting cells with a hemocytometer and by incorporating  3H-
thymidine into DNA (Figure. 1 A and 1 B, respectively), revealed that PFs grow faster than NCFs, 
but while NCFs- grow more slowly than NCFs+, PFs- and PFs+ grow at the same rate.
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Figure 1. Growth rate in NCFs and PFs. For growth rate determination cells were placed at a 
density of 40,000 cell/cm2 in six-well plates and then were incubated for 24 hours in DMEM with 
0.2% FCS to  synchronize  cells  at  a quiescent  state.  Quiescent  fibroblasts  were  then  diluted  in 
complete  growth  medium containing  10% FCS and  incubated  for  further  24  h  hours.  A)  cell 
number as determined by hemocytometer. *NCF- vs NCF+ P<0.05; °PF+ and PF- vs NCF+ and 
NCF-. B) 3H-thymidine incorporated into DNA.  3H-thymidine (10 Ci/ml) was added three hoursμ  
before harvesting cells. Data shown are the mean ± SE of eight NCFs (4 G6PD+ and 4 G6PD-) and 
eight NCFs (4 G6PD+ and 4 G6PD-) made in duplicate. *NCF- vs NCF+ P<0.05; °PF+ and PF- vs 
NCF+ and NCF-.P<0.05.
G6PD activity in  NCFs and PFs
Accordingly, G6PD activity was significantly lower (about 50% less) in NCFs- compared to NCF+, 
but not in PFs – compared to PF+. Also in this case, G6PD activity was significantly higher in PFs, 
both G6PD+ and G6PD- as compared to the corresponding NCFs (Figure 2). These results were 
validated by the finding that mRNA levels of G6PD in the PF- were significantly higher than PF+ 
(Figure 3).
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Figure  2.  G6PD  activity  in  NCFs  and  PFs.  Enzyme  activity  was  measured  in  fibroblast 
homogenates and expressed in mµmoles of NADPH formed per minute per 106  cells. Data shown 
are  the mean ± SE of eight NCFs (4 G6PD+ and 4 G6PD-) and eight NCFs (4 G6PD- and 4 
G6PD+) made in duplicate. *P<0.05 vs G6PD-; °P<0.05 vs NCFs. 
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Figure 3. G6PD mRNA levels in PFs+ and PFs-. Total mRNA was extracted from 106 cells at 
quiescent  state.  mRNA levels  were  determined  by  RT-PCR using  the  appropriate  primer  sets. 
Specific bands were detected after addition of a chemiluminescent substrate, and analyzed by the 
NIH Image 1.63 program (Scion Image). A) Representative blots of G6PD in three PF+ and three 
PF-. B) Densitometric analysis of mRNA levels, normalized for the endogenous -actin mRNAβ  
Data values are represented as mean ± SE. *P < 0.05 vs. PF+.
Determination of neutral lipids in NCFs and PFs
We have demonstrated previously that alterations of lipid metabolism (mainly cholesterol esters, 
CE)  may  represent  important  elements  in the  control  of  cell  proliferation  during  pterygium 
progression (18-20). We therefore also determined neutral lipid in NCFs and PFs (+/-) by directly 
staining cytoplasmic neutral lipid with oil red O (ORO) (Figure 4A and 4B). At time 0, PFs (+/-), 
accumulated more neutral lipids than the corresponding NCFs. Fittingly with cell growth data, the 
cytoplasmic staining became consistently apparent in stimulated PF- but not in NCF- (24h). 
Figure 4. ORO staining of NCFs and PFs. For this experiment, fibroblasts between passages two 
and four of culture were plated at a density of 10.000 cell/cm2 and then incubated for 24 hrs in 
DMEM with 0.2% FCS to synchronize cells at a  quiescent state. Quiescent fibroblasts (0 hours) 
were then diluted in complete growth medium with 10% FCS and incubated for further 24 hours (24 
h). Representative microscopic visualization of neutral lipid accumulation in 2 NCFs (1+ and 1-), 
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and 2 PFs (1+ and 1-)  cell  cultures.  Cells  were  treated with isopropyl  alcohol  (60%), washed, 
stained with ORO and counterstained with Mayer’s hematoxylin. Stained cells were examined by 
light microscopy and digital images recorded. 
NCFs and PFs from G6PD+ and G6PD- subjects were also stained with Nile Red to detect polar 
(i.e., membrane phospholipids, PL) and neutral lipids (i.e., CE), based on the different sensitivity of 
red  (NR-590)  and  yellow (NR-535)  Nile  Red  emissions  for  low and  high-hydrophobic  lipids, 
respectively. Nile Red was used in combination with filipin to co-localize free cholesterol (FC). In 
agreement with ORO data, at 0h, PF+ and PF- showed a higher NR-535 signal (p<0.05), indicative 
of a higher concentration of neutral lipids, mainly cholesterol esters (CE). At 24h the increase was 
significant only for PF-. Neutral lipids were significantly higher in NCFs+ compared to NCFs- at 
the two time points  considered.  A significant  higher  NR-590 signal  and a more  intense filipin 
staining were also observed in PFs+ at 24 h but not in PFs- (data not shown). Taken together these 
data further support the concept that neutral lipid, rather than other polar lipids (i.e. FC and PL) 
have an essential part in the control of cell proliferation and thus that they may represent a target of 
new therapeutic  approaches  for  treatment  and  prevention  of  pterygium  in  particular  and  other 
proliferative disorders in general. Representative images and quantitative data are shown in Figure 
5 A and B, respectively.
0 24
0
25
50
75
100
125
150
*
°
°
°
N
eu
tr
al
 li
pi
d 
in
te
ns
ity
/c
el
l (
ar
bi
tr
ar
y 
un
its
)
hours after FCS stimulation 
 NCF+
 NCF­
 PF+
 PF­
*
°
NFC+ NFC­ PF+ PF­
0h
24h
A
B
Figure  5.  Nile  Red  and  filipin  staining  of  NCFs  and  PFs. A)  Representative  pictures  of 
fibroblasts  stained  with  Nile  Red  and  filipin.  Nile  Red  emissions  (NR-590)  distinguish  low-
hydrophobic  (i.e.,  phospholipids)  by  high-hydrophobic  (i.e.,  triglycerides  and  cholesterol  ester) 
lipids (Nile yellow emissions (NR-535). Filipin stains free cholesterol. B) Quantitative analysis of 
NR-535 staining. Plots show the mean ± SE of the intensity of NR-535 staining fibroblasts. Data 
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were obtained from 6 microscopic fields per group, each field including a total area of 3252 µm of 
cytoplasm (excluding the background). *NCF- vs NCF+, P<0.05; °PF (+/-) vs NCF (+/-), P<0.05.
Autofluorescence in NCFs and PFs
Green autofluorescence in cells,  caused by the formation of conjugated Schiff  base compounds 
from aldehydes derived from lipid peroxidation and amino groups of phospholipids or cell proteins, 
has been proposed as an indicator of oxidative stress (22). Given the role of G6PD in cellular redox 
homeostasis maintenance and considering that oxidative stress induced by UV represents the main 
cause of pterygium, as a final point, we determined green autofluorescence in G6PD normal and 
deficient NCFs and PFs. Representative green autofluorescence images of NCFs (+/-) and PFs (+/-), 
recorded under a 535 nm emission signal, are shown in Figure 6A. At both 0h and 24 h, NCFs- and 
PFs- fluorescence values were significantly higher compared to the corresponding positive cells. At 
the two time points considered, the values in PF (+/-) were significantly higher compared to NCFs 
(+/-) (Figure 6B).
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Figure 6. Green autofluorescence in NCFs and PFs. A) Examples of green autofluorescence in 
NCFs  and PFs.  B)  Quantitative  analysis  of  green  autofluorescence  intensities.  Data  values  are 
represented as mean ± SE from four samples for each group, made in duplicate. At least 50 cells 
were measured for each sample. *P<0.05 vs NCF+ and PF+; °P< 0.05 vs NCF+and NCF-.
DISCUSSION
Maintenance of the intracellular antioxidative system is entirely dependent on sufficient NADPH 
production. NADPH is, in fact, an essential cofactor for maintaining catalase in an active state (23), 
and also serves as a cofactor for glutathione reductase,  which converts the oxidized glutathione 
(GSSG) to its reduced form (GSH) – the major  intracellular  free-radical  scavenger  (24). In the 
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absence of an adequate antioxidant compensatory system, cells may be damaged by environmental 
and biological factors after chronic exposure to them, leading to the activation of oxidative-stress-
sensitive  intracellular  signaling,  which  may  be  ultimately  responsible  for  the  induction  of 
tumorigenic properties (14,25).
Evidence for these mechanisms is extensive, and the accumulation of oxidative damage has often 
been associated with modifications in normal cellular growth control (14,25).
Although NADPH may also be produced by the action of (a)NADP-linked malic enzyme, which 
oxidatively decarboxylates malate to pyruvate; and (b) the mitochondrial  enzyme, NADP-linked 
isocitrate dehydrogenase,  there is compelling evidence that G6PD is the principal  source of the 
NADPH utilized in maintaining cellular redox state within the normal range, and thus in protecting 
cells from oxidative stress (26). However, as the key enzyme in the PPP which provides pentose 
phosphates – precursors of nucleic acids –, G6PD is important for the regulation of cell growth. 
Accordingly,  in  normal  cells,  G6PD  expression  is  tightly  controlled;  while,  in  many  tumors, 
regulation of its expression is altered, resulting in a significant increase in G6PD activity (6,7). 
G6PD deficiency is an inherited disorder characterized by decreased G6PD activity, mainly in red 
blood  cells,  but  actually  also  in  nucleated  cells.  This  decreased  activity  is  not  due  to  enzyme 
synthesis impairment, but rather to reduced enzyme stability (5), which leads to a shortening of its 
half-life. Therefore, a major problem, as yet unsolved, is to understand the underlying mechanisms 
linking G6PD deficiency to oxidative stress and cell growth. In order to address this issue, in the 
present study we utilized fibroblasts isolated from pterygial lesions, both from G6PD+ and G6PD- 
patients,  as  an  experimental  model.  Our  choice  was  determined  by  the  fact  that  pterygium  is 
believed  to  be  induced  by  chronic  oxidative  stress  caused  by  exposure to  UV light,  and  that 
previous studies, done by us and others, showed that pterygium fibroblasts resemble a tumorigenic 
phenotype (15,27). As controls we utilized fibroblasts isolated from conjunctiva from G6PD+ and 
G6PD-  patients  who  had  undergone  cataract  surgery.  The  choice  was  easily  made  since  our 
preliminary epidemiological data had shown a high prevalence of pterygium in G6PD-deficient 
subjects. Growth rate analysis revealed that PFs grow faster than NCFs, but while NCFs- grow 
more  slowly  than  NCFs+,  PFs-  and  PFs+  grow  at  the  same  rate.  This  was  associated  with 
significantly lower G6PD activity in NCFs+ compared to NCFs- (about 50% residual activity, p < 
0.05), while no significant differences in the G6PD activity of PFs+ and PFs- (about 95% residual 
activity) were noted. This result was supported by the finding that in PFs-, G6PD mRNA levels 
were significantly higher than in PFs+, indicating that, under conditions of increased requirement, 
such as induced proliferative stimulus,  G6PD-deficient  nucleated cells overcome the very rapid 
decay of their  mutated enzyme, by producing more protein molecules. Similarly, we previously 
found  higher  G6PD mRNA and activity  levels  in  G6PD-deficient  leukemic  cells  compared  to 
deficient peripheral blood mononuclear cells (PBMC), as well as in G6PD-deficient tumor lung 
tissue compared to normal surrounding tissue (6,7). Another interesting finding of this study was 
increased  autofluorescence  in  both  NCFs-  and  PFs-  compared  to  corresponding  positive  cells, 
indicative  of  pronounced  oxidative  stress  in  deficient  cells.  Finally,  abnormal  accumulation  of 
neutral lipids, mainly cholesterol esters observed both in PFs- and PFs+ compared to NCFs- and 
NCFs+.  These  data  are  in  accordance  with  our  previous  studies  showing  that  intracellular 
accumulation  of  neutral  lipids  represents  an  important  element  in the  control  of  cell 
proliferation(28,29). 
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The results of this study, although restricted to a limited group of subjects (i.e. those of Sardinian 
ancestry), lead to important mechanistic considerations:
i) The  low G6PD activity  found  in  NCFs-  leads  us  to  think  that  these  cells  have  an 
increased vulnerability to reactive oxygen compounds (ROS), such as those induced by 
UV exposure. The consequent low levels of reduced glutathione (GSH), in fact, may not 
permit complete detoxification of the H2O2  produced by intracellular ROS intromission 
(see Figure 7).
ii) Excess H2O2 may interact with,  and modify,  cellular  protein,  lipid, and DNA, which 
would result in altered target cell function (NCF-), leading to selective cell death and a 
compensatory increase in cell proliferation.
iii) Growth-stimulated NCFs- may, through resultant mutated G6PD gene overexpression, 
produce  both  pentose  (for  nucleic  synthesis)  and  NADPH  (for  lipid  synthesis)  in 
amounts sufficiently large to sustain cell division and cell growth progression
Though further studies are necessary for better understanding the exact mechanism which links 
G6PD to oxidative stress and cell proliferation, our data allow to speculate on the role of G6PD 
on tumorigenesis, and to consider G6PD-deficient subjects at major risk to develop common 
and dreaded proliferative disorders, such as atherosclerosis and cancer.
A scheme reassuming the main results found in this study is presented in Figure 7.
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Figure  7:  Proposed  general  theory  of  how  G6PD  deficiency  may  favor  cell  proliferation 
through increased oxidative stress.
A) Cells  are  continuously  exposed to  environmental and biological  factors  leading to Reactive 
Oxygen  Species  (ROS)  formation,  such  as  hydrogen  peroxide  (H2O2).  To  minimize  the 
damaging effects of this molecule, cells have developed a system involving enzymes such as 
catalase and  glutathione peroxidase that convert H2O2 into “benign molecules”, O2  and H2O. 
However, this conversion is not always 100% efficient and residual peroxides may persist in the 
cells,  causing  deleterious  effects.  Glutathione  peroxidase  reduces  H2O2  by  transferring  the 
energy  of  the  reactive  peroxides  to  a  very  small  sulfur-containing  protein  called  reduced 
glutathione (GSH), which in turn is maintained in this form by the action of the glutathione 
reductase. To maintain glutathione in the reduced form, glutathione reductase utilizes NADPH 
provided  by  the  pentose  phosphate  pathway  (PPP),  of  which  G6PD  is  the  key regulatory 
enzyme. In the present study, quiescent fibroblasts, isolated from G6PD- conjunctiva showed 
lower G6PD activity than those from G6PD+ conjunctiva. It is thus reasonable to assume that in 
normal G6PD- cells, H2O2 clearance by scavenging mechanisms occurs at a relatively low rate. 
Therefore, under these conditions, the intracellular persistence of H2O2, may lead to changes in 
signal  transduction  and  gene  expression,  which,  in  turn,  may  give  rise  to  pathological 
conditions, such as proliferative disorders. 
B) By contrast,  G6PD- fibroblasts isolated from pterygium, a fibrovascular conjunctiva growth, 
exhibit G6PD activity similar to G6PD+ pterygium fibroblasts. This result was supported by the 
finding that in PFs-, G6PD mRNA levels were significantly higher than in PFs+. This finding 
leads us to hypothesize that, if oxidative-stress-stimulated G6PD- nucleated cells overcome the 
very rapid decay of their mutated enzyme by overproducing G6PD. This leads stimulated cells 
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to produce sufficient amounts of pentose for nucleic acid synthesis, and of NAPDH for lipid 
synthesis, in order to sustain growth.
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